Publicaciones en colaboración con investigadores/as de King's College Hospital (25)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

    Blood Advances, Vol. 7, Núm. 11, pp. 2645-2655

2022

  1. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

    Frontiers in Oncology, Vol. 12

2021

  1. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 78, Núm. 8, pp. 840-853

  2. Nomenclature in nephrology: preserving ‘renal’ and ‘nephro' in the glossary of kidney health and disease

    Journal of Nephrology, Vol. 34, Núm. 3, pp. 639-648

  3. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108

  4. Safety and effectiveness of coronary intravascular lithotripsy in eccentric calcified coronary lesions: a patient-level pooled analysis from the Disrupt CAD I and CAD II Studies

    Clinical Research in Cardiology, Vol. 110, Núm. 2, pp. 228-236

2020

  1. Angiography-derived functional assessment of non-culprit coronary stenoses in primary percutaneous coronary intervention

    EuroIntervention, Vol. 15, Núm. 18, pp. E1594-E1601

  2. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854

2019

  1. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document

    Circulation, Vol. 140, Núm. 5, pp. 420-433

  2. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

2018

  1. State of transcatheter aortic valve implantation in Spain versus Europe and non-European countries

    Journal of Invasive Cardiology, Vol. 30, Núm. 8, pp. 301-309

2017

  1. Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents

    Journal of the American College of Cardiology, Vol. 70, Núm. 1, pp. 60-74

  2. Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey

    International Journal of Cardiology, Vol. 228, pp. 640-647

  3. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial

    European Journal of Heart Failure, Vol. 19, Núm. 11, pp. 1545-1550

2016

  1. Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals

    Medicine (United States), Vol. 95, Núm. 41

  2. The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

    EuroIntervention, Vol. 12, Núm. 1, pp. 79-87

  3. The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

    JACC: Cardiovascular Interventions, Vol. 9, Núm. 12, pp. 1231-1242

2015

  1. Conversion, correction, and international scale standardization: Results from a multicenter external quality assessment study for BCR-ABL1 testing

    Archives of Pathology and Laboratory Medicine, Vol. 139, Núm. 4, pp. 522-529

  2. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure

    Journal of Hepatology, Vol. 62, Núm. 4, pp. 831-840